Fibroblast growth factor 23 predicts carotid atherosclerosis in individuals without kidney disease. The CORDIOPREV study
- 1 April 2020
- journal article
- research article
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 74, 79-85
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Fibroblast Growth Factor-23 and Death, Heart Failure, and Cardiovascular Events in Community-Living IndividualsJACC, 2012
- FGF23 induces left ventricular hypertrophyJournal of Clinical Investigation, 2011
- FGF-23 Associates with Death, Cardiovascular Events, and Initiation of Chronic DialysisJournal of the American Society of Nephrology, 2011
- Regulation of serum 1,25(OH)2Vitamin D3levels by fibroblast growth factor 23 is mediated by FGF receptors 3 and 4American Journal of Physiology-Renal Physiology, 2011
- Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patientsNephrology Dialysis Transplantation, 2010
- Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the communityAtherosclerosis, 2009
- Relationship between circulating FGF23 and total body atherosclerosis in the communityNephrology Dialysis Transplantation, 2009
- High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patientsNephrology Dialysis Transplantation, 2009
- Fibroblast Growth Factor 23 and Mortality among Patients Undergoing HemodialysisNew England Journal of Medicine, 2008
- Klotho converts canonical FGF receptor into a specific receptor for FGF23Nature, 2006